Message Font: Serif | Sans-Serif
No. of Recommendations: 0
A few opinions from our AOL boards...

Subj: VIMRX/Baxter Joint Venture
Date: 04 Jun 1997 12:31:34 EDT
From: Jim6317
Message-ID: <>

I'm a shareholder of VIMRX Pharm (VMRX). Rumor has it they are in discussions with quite a few pharm co's in a JV for their Oligozyme technology developed by a subsidiary -Innovir (INVR). Baxter is said to be the front runner. Anything heard on this end?


Subj: Strong Buy Recommendation
Date: 23 May 1997 13:37:13 EDT
From: TMF Elwood
Message-ID: <>

CS First Boston said it initiated coverage of Baxter International Inc <BAX.N> with a strong buy recommendation.


Subj: Re: Re:Blood Substitute
Date: Sat, 19 Apr 1997 10:18:23 EST
From: LewA838328
Message-ID: <>

According to Value Line the blood substitute poduct (called HemAssist) will go on sale in Europe in early 98. and in the US about a year later. Value Line sales estimates for 98 include 100 million for the blood substitute product! Its potential world market probably approaches 3 Billion.

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.